Avibactam
Back to searchMolecule Structure
Scientific Name
Avibactam
Description of the Drug
Avibactam is a non-β-lactam β-lactamase inhibitor used in combination with ceftazidime for the treatment of complicated intra-abdominal infections, complicated urinary tract infections, and hospital or ventilator-acquired pneumonia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09060
http://www.drugbank.ca/drugs/DB09060
Brand Name(s)
Nxl-104
Company Owner(s)
Allergan Sales Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Bacterial beta-lactamase TEM | SINGLE PROTEIN | INHIBITOR | CHEMBL2364670 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL15942023 | SCHEMBL1666807 |
| DrugBank | DB09060 | |
| PubChem: Thomson Pharma | 14795217 | |
| PubChem | 90333665 | 9835049 |
| Nikkaji | J3.098.586I | |
| PDBe | FYG | |
| BindingDB | 50339145 | |
| DrugCentral | 4946 | |
| Brenda | 206585 | 206594 |
| ChemicalBook | CB02582836 | |
| Guide to Pharmacology | 10761 | |
| rxnorm | AVIBACTAM SODIUM | AVIBACTAM |
| ChEBI | 85984 | |
| ZINC | ZINC000009302239 |
